Year: 2024

RJVA-001 was successfully delivered in large animal Yucatan pig models at low total viral dose Results confirm ability to directly target pancreas with novel delivery catheter and route of administration Local delivery of RJVA-001 achieved therapeutically relevant GLP-1 expression within pancreatic beta cells with no adverse safety effects observed Company plans to initiate first-in-human studies with RJVA-001 in first half of 2025 BURLINGTON, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) — Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pioneering pattern breaking approaches for the treatment of obesity and type 2 diabetes (T2D), will present new data from its preclinical Rejuva Smart GLP-1 pancreatic gene therapy program in a poster titled “Feasibility and Safety of Novel Endoscopic Ultrasound-Guided...

Results Release and Webinar Discussion on Morning of December 19, 2024 MISSISSAUGA, Ontario, Dec. 12, 2024 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it expects to file the financial statements and management disclosure and analysis for its fourth quarter of fiscal 2024 ended September 30, 2024 (“Q4 2024”) prior to the start of trading on December 19, 2024. At 11:00 AM ET on that day, Microbix intends to hold a webinar discussion of Q4 2024 results with its CEO, CFO, and COO. Investor and shareholders can participate in the webinar, hosted by Adelaide Capital, by registering at: https://us02web.zoom.us/webinar/register/WN_-iYkOhR_SeWwzGxUmbPjRw. It will also be live-streamed to YouTube at: https://www.youtube.com/channel/UC7Jpt_DWjF1qSCzfKlpLMWw. Telephone...

Wendy Chang appointed Chief People Officer; Haibo Wang appointed Chief Business Officer SAN DIEGO, Dec. 12, 2024 (GLOBE NEWSWIRE) — Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancers, today announced the appointment of Wendy Chang as Chief People Officer and Haibo Wang as Chief Business Officer. “Zentalis is sharply focused on our goal of bringing azenosertib to patients with gynecological malignancies,” said Julie Eastland, Chief Executive Officer. “To support this goal, we are continuing to tune our leadership team and today announced the appointment of two talented leaders with a strong track record of successfully supporting organizations through...

London, UK, Dec. 12, 2024 (GLOBE NEWSWIRE) — Blink Charging UK (“Blink UK”), a subsidiary of Blink Holdings BV, a wholly owned subsidiary of Blink Charging Co., a leading global manufacturer, owner, operator and provider of electric vehicle (EV) charging equipment and services, today announced the Company has been awarded a three-year contract to install, maintain and manage 41 electric vehicle (EV) chargers and contactless payment terminals at Kings College NHS Trust’s flagship Princess Royal University Hospital. Beginning May 2025, hospital patients, visitors, and staff will be able to charge their EVs quickly and easily at one of 41 new charging bays and pay seamlessly using one of the new 21 contactless payment terminals. In the project’s first phase, Blink UK will install new chargers in the hospital car park, with 35...

Updated Phase 1 data include a 16.3-month median recurrence-free survival (“mRFS”) and 28.9-month median overall survival (“mOS”) from full study population Strong correlation observed between mRFS and strength of T cell response Event-driven interim analysis from randomized Phase 2 trial expected in H1 2025 BOSTON, Dec. 12, 2024 (GLOBE NEWSWIRE) — Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, presented updated results from the Phase 1 AMPLIFY-201 clinical trial (NCT04853017) of ELI-002, an Amphiphile (“AMP”) cancer vaccine that targets KRAS-mutant tumors, at the ESMO Immuno-Oncology Congress 2024 in Geneva, Switzerland. ELI-002 was evaluated in individuals with mutant KRAS (“mKRAS”)-driven...

SmartGateway Deployment at all Major College Access Points TORONTO, Dec. 12, 2024 (GLOBE NEWSWIRE) — Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced its SmartGateway has been selected by Bowie State University, located in Bowie, Maryland, to enhance safety across campus, including at athletic facilities and on-campus housing. The initial deployment, which took place this fall, was made possible through Xtract One’s partnership with Core Secure LLC, a security solutions integrator and hardware provider. “At Bowie State University, we recognize that advanced security measures are crucial for protecting our community,” said Mark Cummings, Director of Public Safety and Chief of Campus Police at Bowie State University. “It’s important for us to foster a safe campus environment...

Company Prepares to Drill 7-30 and 7-15 Oil Locations – Sets Stage for Additional 10 Well Drilling Program CALGARY, Alberta, Dec. 12, 2024 (GLOBE NEWSWIRE) — First Helium Inc. (“First Helium” or the “Company”) (TSXV: HELI) (OTCQB: FHELF) (FRA: 2MC) today announced receipt of regulatory licensing approval to proceed with the drilling of its proven undeveloped (“PUD”) 7-30 location, which has been assigned proved plus probable undeveloped reserves of 196,700 barrels2 by Sproule Associates Limited (“Sproule”)1, its independent evaluator. The Company continues to advance the licensing process for its high-impact 7-15 Leduc anomaly target and is working to secure drilling and ancillary services to drill both wells in a sequential, cost-effective manner. “With drilling license in hand for the 7-30 PUD location, we are moving ahead to...

PRINCETON, N.J., Dec. 12, 2024 (GLOBE NEWSWIRE) — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announced today that management will host in-person investors meetings in San Francisco alongside the 43rd Annual J.P. Morgan Healthcare Conference being held January 13-15, 2025, in San Francisco, CA. ICR Healthcare is coordinating meetings on the Company’s behalf. To schedule a meeting with Dr. Phillip Chan, Chief Executive Officer, and Peter J. Mariani, Chief Financial Officer, please send requests to ICR Healthcare at ir@cytosorbents.com. About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...

TORONTO, Dec. 12, 2024 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Corporation“) (TSXV: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer™, Photonic Integrated Circuits (PICs) and light sources for the data center, tele-communication and artificial intelligence markets, today announces its intention to complete a non-brokered public offering of 5,000,000 units of the Corporation (the “Units“) at a price of US$5.00 (C$7.08) per Unit (the “Issue Price“) for aggregate gross proceeds to the Corporation of US$25 million (the “Offering“). Each Unit will be comprised of one common share of the Corporation (each, a “Common Share“) and one-half of one common share purchase warrant of the Corporation (each whole common...

NEW YORK, Dec. 12, 2024 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a leading global lifestyle and consumer packaged goods company, is pleased to present the official launch of Herb & Bloom, a line of ready-to-drink, non-alcoholic, effervescent beverages that are cocktail-inspired. Herb & Bloom’s initial launch of beverages are infused with 5mg of carefully sourced natural hemp-derived Delta-9 THC. Herb & Bloom’s Art Deco design reflects timeless sophistication. Its stylish and elegant collection is designed to evoke the art and golden age of cocktails. Herb & Bloom’s visual aesthetic is only the start. Inside each can is a harmonious blend of refreshing fruit flavors creating a smooth and balanced drinking experience. The initial launch features three re-imagined classic flavors for any...